Powering High-Value Decisions with
Precision Insights
Since 1998, Kalorama, part of Science and Medicine Group, has been a trusted leader in life science market intelligence for top IVD manufacturers, investors, and healthcare stakeholders. While others spread thin across multiple verticals, we go deep – specializing in sectors like IVD, medical devices, biotechnology, and pharmaceuticals. Our goal is simple: turn data into clear actionable insights so business can make smarter decisions, identify growth opportunities, and stay ahead of change.
Industries We Serve
Healthcare • Biotechnology • Laboratory Diagnostics • Medical Devices • Pharmaceuticals
Our Solutions
Explore our comprehensive suite of solutions, designed to drive your success. Why? Because when you succeed, science and medicine move forward.
Latest Resource
Clinical Proteomics Moves Closer to Patient Care
August 26, 2026
Daniel Granderson
The clinical proteomics market reached an estimated $456 million in 2025 and is expected to grow at a double-digit compound annual growth rate (CAGR) through 2030, according to Kalorama Information’s The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030. Yet despite the name, most modern market activity takes place outside routine patient care. Much…
Latest Market Reports
Our syndicated reports are vital tools for companies aiming to develop and implement effective market strategies. View our latest reports below.
In Vitro Diagnostics Business Outlook, 2026
August 24, 2026
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…
Price range: $7,000.00 through $10,000.00
The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030
August 19, 2026
Kalorama’s 105-page clinical proteomics report sizes the market by technology and region through 2030, covering mass spectrometry, high-plex affinity assays, digital immunoassays, and spatial proteomics, with company profiles of 16 vendors and analysis of deals, approvals, and trends from 2021 to 2026.
Price range: $5,600.00 through $8,000.00
Worldwide Market for Clinical Laboratory Services, 11th Edition
July 31, 2026
Now in its 11th edition, Kalorama Information’s flagship review of clinical laboratory services gives decision-makers a rigorous, independent read on where diagnostic testing revenue sits today and where it is heading. Built on a 2025 base year, with historical data spanning 2020–2024 and forecasts running through 2030, the report is the reference stakeholders use to…
Price range: $5,950.00 through $8,500.00
Our Customers
